|
HS Code |
557584 |
| chemical_name | Fructose 1,6-diphosphate |
| synonyms | Fructose 1,6-bisphosphate, FDP |
| molecular_formula | C6H14O12P2 |
| molecular_weight | 340.12 g/mol |
| CAS_number | 488-69-7 |
| appearance | White crystalline powder |
| solubility_in_water | Highly soluble |
| storage_conditions | Store at -20°C, protected from light and moisture |
| purity | ≥98% (HPLC) |
| pH_value | Neutral to slightly acidic (when dissolved in water) |
| biological_role | Key intermediate in glycolysis |
| stability | Stable under recommended storage conditions |
As an accredited Fructose 1 6-Diphosphate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, tightly sealed plastic bottle containing 10 grams of Fructose 1,6-Diphosphate, labeled with chemical details, hazards, and batch number. |
| Shipping | Fructose 1,6-diphosphate should be shipped at controlled room temperature, protected from moisture and light. It must be securely packaged in leak-proof, chemically resistant containers and labeled in accordance with chemical safety regulations. For international transport, ensure compliance with IATA, IMDG, and relevant local shipping guidelines for laboratory chemicals. |
| Storage | Fructose 1,6-diphosphate should be stored in a tightly closed container at -20°C, protected from light and moisture. The chemical is sensitive to air and humidity, and should be kept in a dry environment. Use gloves when handling, and store in a designated chemical storage area, away from incompatible substances such as strong acids or bases. |
| Purity 99%: Fructose 1 6-Diphosphate with 99% purity is used in biochemical enzyme assays, where it ensures high specificity and reproducibility in reaction kinetics.Molecular Weight 340.14 g/mol: Fructose 1 6-Diphosphate with a molecular weight of 340.14 g/mol is used in metabolic pathway studies, where consistent molecular mass supports accurate metabolic flux analysis.Stability Temperature 4°C: Fructose 1 6-Diphosphate stable at 4°C is used in pharmaceutical formulation storage, where its stability preserves compound integrity for extended shelf life.Particle Size <10 µm: Fructose 1 6-Diphosphate with particle size below 10 µm is used in injectable drug delivery systems, where fine particle dispersion enhances bioavailability.pH Range 6.8–7.2: Fructose 1 6-Diphosphate effective in pH range 6.8–7.2 is used in buffer preparation for cell culture experiments, where it maintains physiological conditions for optimal cell growth.Water Solubility >95%: Fructose 1 6-Diphosphate with water solubility over 95% is used in intravenous nutrition solutions, where high solubility allows for rapid systemic absorption.Endotoxin Level <0.1 EU/mg: Fructose 1 6-Diphosphate with endotoxin level below 0.1 EU/mg is used in clinical research trials, where low endotoxin minimizes immunogenic response in subjects.Melting Point 184°C: Fructose 1 6-Diphosphate with a melting point of 184°C is used in thermal stability testing of pharmaceuticals, where heat resistance supports robust formulation development. |
Competitive Fructose 1 6-Diphosphate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In chemical manufacturing, producing Fructose 1,6-Diphosphate stands out for a few unique reasons. This compound, usually abbreviated as FDP or F1,6DP, forms part of the core biochemistry found in every living cell, but synthesizing it at industrial scale presents its own challenges and rewards. Every technician and engineer who has worked with this molecule quickly sees how much attention to detail goes into the process, right from choosing the right grade of materials to maintaining stable processing environments.
Unlike more straightforward sugars or phosphate derivatives, Fructose 1,6-Diphosphate leads to unique requirements during synthesis and purification. Some think of it as just another metabolic intermediate, but full control over purity levels and moisture content separates lab samples from true industrial-grade material. In a working facility, one learns that small variations in reaction control or feedstock quality can impact the final result in measurable ways, especially if customers expect material free from ions that might complicate biological assays or pharmaceutical processes.
The batch-to-batch repeatability we achieve in our facilities involves in-house insights into the reaction kinetics of fructose phosphorylation and the nuanced steps needed for diphosphorylation. We produce Fructose 1,6-Diphosphate sodium salt as a crystalline powder, often in models characterized by their concentration and degree of hydration. Common requests from clients include anhydrous forms or tetrahydrate, and these have distinct processing steps that can’t be shortcut without affecting both shelf-life and downstream usability.
Our output typically reaches a purity above 98%, confirmed using modern chromatographic and spectrometric methods. Clients in the pharmaceutical sector appreciate that we have protocols supporting not just chemical purity, but also quantifiable absence of endotoxins, metals, and other residuals. For those sourcing for food additives, traceability and documentation satisfy regulatory needs, but it’s always the reality on the production floor that dictates whether we hit the tightest marks batch after batch. Paperwork alone cannot make up for attention paid to every valve setting or filtration sequence.
Every time a new request arrives, it becomes clear how Fructose 1,6-Diphosphate finds its way into projects beyond pure research. Medical teams use it during cardiac procedures due to its influence on cellular metabolism. In metabolic shock or ischemia, some clinicians depend on promptly delivered high-purity FDP to support organ preservation or assist in recovery—a responsibility that weighs heavily on our end, driving every improvement in our protocols. Missed specs here don’t just cost an order; they can limit a treatment option for critical care patients.
Biotechnology companies working on enzymes often look to us for consistently pure material to drive their reactions and calibrate assays. In many applications, interference from trace ions or breakdown products leads to unpredictable results in enzyme kinetics. Animal studies sometimes draw on injectable forms, where the balance of safety, stability, and sterility in the ingredient list circles back to how cleanly we can separate our product from residual reagents. Some agricultural projects even explore its metabolic impact in plants and livestock.
Compared to glucose phosphates or other simple mono-phosphorylated sugars, Fructose 1,6-Diphosphate brings a specific dual-phosphate structure that plays a distinctive part in glycolysis. Users looking for this compound rarely accept substitutes. Even structurally close molecules like Fructose 6-Phosphate can’t fill the same in vitro or clinical roles—each has its particular kinetic profile and regulatory behavior. We learned over years of making both that process tuning needs to match the chemistry of the exact molecule, as small deviations may generate byproducts or degradation during storage.
It’s common for teams in purchasing or R&D to ask about the interchangeability between diphosphates and monophosphates. In practice, the extra phosphate group changes not just function, but also how the material tolerates heat, humidity, and exposure to air. Storage, stability testing, and final packaging all take on new significance. Our laboratory always produces clear documentation, but our real perspective comes from maintenance logs and production notes—details that make a difference when someone needs a dry, stable powder months after production.
Many in the industry underestimate the time saved by crews who routinely inspect seals, assess powder flow, and monitor storage temperatures. We’ve observed midway through bulk orders how ambient humidity or minor mishandling causes lumps or caking in some batches. Over years, feedback from clients dealing with packing or dissolving issues led us to modify filling lines and invest in better environmental control on shipping docks.
Powders of Fructose 1,6-Diphosphate have a natural tendency toward deliquescence, especially at high humidity. Standard warehouse practices don’t cut it; we learned to ship in vacuum-sealed, high-barrier liners and recommend refrigeration if not used promptly. Once hydration sets in, even small amounts, reprocessing doesn’t always recover quality. Instead, upstream controls at crystallization and rapid, low-temperature drying became part of our normal operation. Such routines have salvaged more than one international shipment from disappointment.
Years back, the main market for Fructose 1,6-Diphosphate revolved around standard biochemical studies, enzyme research, and clinical trials. Then, expanded research into ischemic heart protection, and even therapies under investigation for sepsis, brought new attention from hospitals and research labs. Chemical manufacturers stepped into a larger role supporting the clinical world. Our work changed—raw data and material tracking became as vital as cost and logistics. Sample traceability, reference spectra, and batch certifications are now discussed as much as reagent price. We evolved alongside these shifts, learning the stakes behind every order.
Colleagues in university labs occasionally request small-scale, highly characterized material, seeking low amounts of sodium or calcium. Often, these requests spring from insights on downstream effects—certain applications show measurable differences even with half a percent impurity. Our technical team often partners with those researchers through production runs, sharing real-time analytics to reach the exact profile needed for a particular study. Sometimes this means halting lines or adjusting cleaning schedules on the fly—effort that goes unseen outside the plant, but matters deeply to those making the final application.
We learn from customers on nearly every order. Some want extra-fine powder for precise dissolution in high-throughput pharm labs. Others seek a coarser cut for dry mixing or automated feeders in process lines. Several projects over the years raised questions on how the sodium salt form behaves under stress, prompting us to investigate alternative salt forms or coatings that hold up better during shipping or storage. Change doesn’t come from top-down directives alone, but through plant operators noticing a clog, a moisture spike, or an ordering pattern that hints at a recurring issue on the user’s end.
Once, a pharmaceutical partner flagged minor batch-to-batch shifts in solubility that we tracked down to a change in a supplier’s water quality. Instead of easy fixes, solutions ran deeper—changing in-line filtration, realigning our internal water testing, and securing alternative suppliers with matching specs. The work behind each lot reflects layers of real encounters, hiccups, and improvements, not just adherence to abstract quality manuals.
Quality and traceability don’t end at the factory door. Reliable Fructose 1,6-Diphosphate production means long-term partnerships with suppliers who share our demand for low-metal, consistent feedstocks. Years of experience taught us that deviations in raw material handling or batch age impact crystallization yields and introduce problematic contaminants. By documenting and auditing every step, we reduce surprises—but it’s constant vigilance on the receiving dock and during pre-synthesis checks that protects finished product reliability.
Changes in sugar crop harvests, for example, directly influence starting substrate variability. Instead of responding only once a problem appears, quality control staff keep up seasonal batch studies, anticipating shifts in impurity levels brought on by environment, transport, or interim processing. We’ve learned that the stability of our product, especially in medical contexts, comes from control that starts well before any reagents touch our reactors.
As the chemical industry faces growing scrutiny on waste and emissions, our own experience mirrors these pressures. The synthesis of Fructose 1,6-Diphosphate uses phosphate donors and energy-intensive purification steps that, if unmanaged, generate phosphorous waste and high-salt effluent. Historically, many ignored the footprint but today, our production lines directly recycle process water, isolate secondary phosphate streams, and optimize yields to keep waste to a minimum. Investments in modern automation let us track and reduce chemical usage or energy drawn at each toll gate.
We have shifted over a decade from batch processing to more continuous lines, which cuts holding times and reduces opportunities for contamination or unnecessary waste. These operational changes came not only from regulatory nudges but from direct operator suggestions backed by energy and waste audits. That expertise grew naturally—no amount of external consulting could have replaced the hands-on process knowledge from day-in, day-out observation on the shop floor.
Trends in pharmaceuticals, diagnostics, and biotech keep raising the standards for every order of Fructose 1,6-Diphosphate. Those on the frontlines of chemical manufacturing see not just a commodity, but a molecule whose journey from batch kettle to shipment box captures all the lessons, problems, and innovations that shape a modern synthesis plant.
Researchers exploring new therapeutic avenues with FDP rely on supply chains committed to transparency, low variability, and rapid response if any issue appears. As manufacturers, we draw satisfaction from seeing our product play a part in advancing human health and science. The best changes in our process came from direct interaction with practical user challenges—untangling a solubility question, adjusting for a new regulatory limit, or innovating a drier packing line after hearing about field failures. That’s the reality behind each shipment and the encouragement to keep refining our methods.
Distributors and third parties often frame Fructose 1,6-Diphosphate solely by catalog numbers, test results, or logistics, but only manufacturers contend with the messy, detailed reality of getting a high-purity product out the door on time, every month, every year. A trader can recite purity ranges, but someone running the reactors knows the impact of every raw material shipment, errant temperature probe, or slight change in reaction pH.
Clients working with us for the long term develop a real understanding that no two lots are truly interchangeable without diligent control and documentation. The bond between manufacturer and customer grows with every shared solution, every improvement chased through direct communication and technical insight, not just transactional service. This relationship builds resilience, especially when global events or supply disruptions appear unannounced.
Making Fructose 1,6-Diphosphate for today’s demanding scientific and medical applications calls for more than adherence to published methods. All the subtle lessons learned from years of hands-on production make up the difference between a generic batch and material that truly supports critical human needs. Each modification comes from hard-won experience—never guesswork or generic compliance. We stand by every shipment, shaped by a reality where quality is earned through vigilance, partnership, and respect for the chemistry at hand.